AbbVie Archives -

Reata rockets on data for Nrf2 drug reacquired from AbbVie

https://pharmaphorum.com/news/reata-rockets-on-data-for-nrf2-drug-reacquired-from-abbvie/

Humira tops list of drugs with unwarranted US price hikes

https://pharmaphorum.com/news/humira-tops-list-of-drugs-with-unwarranted-us-price-hikes/

ESMO 2019 roundup

https://pharmaphorum.com/views-analysis-oncology/esmo-2019-roundup/

ESMO 2019 – new data could unlock bigger market for PARP inhibitors

https://pharmaphorum.com/news/esmo-2019-new-data-could-unlock-bigger-market-for-parp-inhibitors/

The Pharma Comms Impact Conference – For Internal & External

https://pharmaphorum.com/events/the-pharma-comms-impact-conference-for-internal-external/

Unions call on US antitrust regulators to block $63 billion ‘AbbVieGan’ merger

https://pharmaphorum.com/news/unions-call-on-us-antitrust-regulators-to-block-63-billion-abbviegan-merger/

Rova-T: the story of AbbVie’s multi-billion dollar failure

https://pharmaphorum.com/r-d/views-analysis-r-d/rova-t-the-story-of-abbvies-multi-billion-dollar-failure/

The top pharma companies by revenue 2018

https://pharmaphorum.com/views-and-analysis/the-top-pharma-companies-by-revenue-2018/

AbbVie axes multi-billion cancer flop Rova-T after another trial fails

https://pharmaphorum.com/news/abbvie-axes-multi-billion-cancer-flop-rova-t-after-another-trial-fails/

Search